Relationship of aspirin use with age-related macular degeneration: Association or causation?

JAMA Internal Medicine

Volumn 173, Issue 4, 2013, Pages 264-266

  Kaul, Sanjay ^a   Diamond, George A ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

BODY MASS; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG USE; FOLLOW UP; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; LOW DRUG DOSE; NOTE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA MACULA AGE RELATED DEGENERATION; SELF REPORT; SYSTOLIC BLOOD PRESSURE;

ASPIRIN; FEMALE; HUMANS; MACULAR DEGENERATION; MALE;

EID: 84874882485     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.2530     Document Type: Note

References (10)

1. Liew G, Mitchell P, Wong TY, Rochtchina E, Wang JJ. The association of aspirin use with age-related macular degeneration [published online January 21, 2013]. JAMA Intern Med. 2013;173 (4): 258-264.
2. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58 (5): 295-300.
3. Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL III; Age-Related Eye Disease Study Research Group. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report No. 19. Ophthalmology. 2005;112 (4): 533-539.
4. Klein R, Klein BE, Jensen SC, et al.Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol. 2001;119 (9): 1354-1359.
5. de Jong PT, Chakravarthy U, Rahu M, et al. Associations between aspirin use and agingmacula disorder: the European Eye Study. Ophthalmology. 2012; 119 (1): 112-118.
6. Christen WG, Glynn RJ, Ajani UA, et al. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol. 2001;119 (8): 1143-1149.
7. Christen WG, Glynn RJ, Chew EY, Buring JE. Low-dose aspirin and medical record confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology. 2009;116 (12): 2386-2392.
8. Baigent C, Blackwell L, Collins R, et al Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373 (9678): 1849-1860.
9. Seshasai SR, Wijesuriya S, Sivakumaran R, et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med. 2012;172 (3): 209-216.
10. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150 (6): 396-404.